Astellas Inks Second CAR-T Agreement with Poseida to Develop ‘Convertible’ Cancer Therapies
Astellas Inks Second CAR-T Agreement with Poseida to Develop ‘Convertible’ Cancer Therapies 5/2/2024
Astellas Inks Second CAR-T Agreement with Poseida to Develop ‘Convertible’ Cancer Therapies 5/2/2024